Author

Xiaofeng Yang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Esteban Delgado· 1 shared H T Liu· 1 shared Jianan ZhaoiD· 1 shared Jingjing PangiD· 1 shared Liam FlynniD· 1 shared Long Nguyen Hoang Do· 1 shared Michael V. AutieriiD· 1 shared Xiaolei LiuiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

Esteban Delgado

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pan-Peroxisome Proliferator-Activated Receptor Agonist IVA337 Alleviates Secondary Lymphedema via Inhibiting TGFβ/SMAD2/3 Signaling Pathway

Jingjing Pang, Long Nguyen Hoang Do, Esteban Delgado, Jianan Zhao, Liam Flynn, H T Liu, Michael V. Autieri, Xiaofeng Yang, Xiaolei Liu

This study shows that IVA337 reduces secondary lymphedema in mice by inhibiting the TGFβ/SMAD2/3 pathway, improving lymphatic function and preventing fibrosis.

Vascular Pharmacology · Aug 29, 2026Peer-reviewedPathology